Atlas Trials

Phase II ABT-888 With Cyclophosphamide

Clinical trial NCT01306032 · COMPLETED

Trial details

NCT number
NCT01306032
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ovarian CancerPrimary Peritoneal CancerSerous Carcinoma CancerTriple-Negative Breast CancerFallopian Tube Cancer
Start date
2011-01-12
Primary completion
2014-12-31
Enrollment
124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.